HAE
Showing 1 - 25 of 316
Lanadelumab in Teenagers and Hereditary Angioedema (HAE)
Not yet recruiting
- Hereditary Angioedema (HAE)
- No Intervention
-
London, England, United KingdomBarts Health NHS Trust
Jul 20, 2022
Hereditary Angioedema Who Currently Receive Icatibant at Home
Not yet recruiting
- Hereditary Angioedema (HAE)
- No Intervention
-
London, United KingdomSciensus
Aug 4, 2022
Hereditary Angioedema Trial in Amsterdam, Auckland, Cambridge (Biological NTLA-2002, Normal Saline IV Administration)
Recruiting
- Hereditary Angioedema
- Biological NTLA-2002
- Normal Saline IV Administration
-
Amsterdam, Netherlands
- +2 more
Jul 18, 2022
Hereditary Angioedema, HAE Trial in Japan (BCX7353 capsules, Placebo oral capsule)
Completed
- Hereditary Angioedema, HAE
- BCX7353 capsules
- Placebo oral capsule
-
Chiba, Japan
- +9 more
Jan 12, 2023
Hereditary Angioedema (HAE) Trial (CSL312)
Not yet recruiting
- Hereditary Angioedema (HAE)
- CSL312
- (no location specified)
Apr 17, 2023
Teenagers and Non-histaminergic Angioedema With Normal C1
Not yet recruiting
- Hereditary Angioedema (HAE)
- Angioedema
- No Intervention
- (no location specified)
Jan 5, 2023
Hereditary Angioedema Trial (KVD900 600 mg)
Not yet recruiting
- Hereditary Angioedema
- KVD900 600 mg
- (no location specified)
Aug 19, 2022
Lanadelumab in Participants With Hereditary Angioedema
Recruiting
- Hereditary Angioedema (HAE)
-
Tokyo, T, JapanTakeda selected site
Jun 22, 2022
Lanadelumab in Persons With Hereditary Angioedema in Poland
Recruiting
- Hereditary Angioedema (HAE)
-
Wrocław, Dolnośląskie, Poland
- +13 more
Jun 15, 2022
Hereditary Angioedema, HAE Trial in United States (Dose 1 of BMN 331, Dose 2 of BMN 331, Dose 3 of BMN 331)
Recruiting
- Hereditary Angioedema
- HAE
- Dose 1 of BMN 331
- +4 more
-
Birmingham, Alabama
- +11 more
Jan 26, 2023
Teenagers and Hereditary Angioedema Type I or Type II Who Use
Completed
- Hereditary Angioedema (HAE)
-
Graz, Austria
- +19 more
Jan 12, 2023
ANGIOEDEMA Trial in Grenoble (angioedema)
Recruiting
- ANGIOEDEMA
- angioedema
-
Grenoble, Isere, FranceUniversity Hospital Grenoble
Oct 29, 2021
Hereditary Angioedema Trial (KVD900 600 mg)
Not yet recruiting
- Hereditary Angioedema
- KVD900 600 mg
- (no location specified)
Aug 17, 2022
Natural History Study of Patients With HPDL Mutations
Recruiting
- Mitochondrial Encephalomyopathies
- +6 more
- Patient Registry
- Dry blood spots sampling
-
San Diego, CaliforniaEun Hae Lee
Apr 28, 2023
Lanadelumab in Teenagers and Hereditary Angioedema in Argentina
Recruiting
- Angioedemas, Hereditary
-
Ciudad Autónoma de Buenos Aires, Buenos Aires, ArgentinaIc Projects Srl
Sep 8, 2021
Hereditary Angioedema (HAE) Trial in Worldwide (Lanadelumab)
Available
- Hereditary Angioedema (HAE)
- Angioedema
- Lanadelumab 150 mg
- Lanadelumab 300 mg
-
Scottsdale, Arizona
- +19 more
Sep 16, 2022
Hereditary Angioedema (HAE) Trial (ecallantide)
Withdrawn
- Hereditary Angioedema (HAE)
- ecallantide
- (no location specified)
May 14, 2021
Hereditary Angioedema (HAE) Trial in Wheaton (ecallantide, Phosphate Buffer Saline (PBS),)
Completed
- Hereditary Angioedema (HAE)
- ecallantide
- Phosphate Buffer Saline (PBS),
-
Wheaton, MarylandInstitute for Asthma and Allergy
Jun 3, 2021
Hereditary Angioedema Trial in Milano (Icatibant, Tranexamic Acid, Oral Placebo)
Completed
- Hereditary Angioedema
- Icatibant
- +3 more
-
Milano, ItalyUniversità degli Studi di Milano, Dipartimento di Medicina Inter
May 24, 2021
Hereditary Angioedema (HAE) Trial in Japan (CINRYZE 500 U, CINRYZE 1000 U)
Completed
- Hereditary Angioedema (HAE)
- CINRYZE 500 U
- CINRYZE 1000 U
-
Toyohashi, Aiti, Japan
- +9 more
May 13, 2021